GlobalData on MSN
Otsuka’s ADHD drug reduces symptoms in Phase IIIb trial
Otsuka’s ADHD drug centanafadine is currently under review by the US FDA, with a PDUFA date of 24 July 2026.
Are ADHD medications overprescribed in kids? Are too many kids taking ADHD medication? Understood examines the question of whether stimulant medications for ADHD are overprescribed, which has been ...
ADHD patients deserved a more consistent, safe and manageable medication experience. Imagining a better way forward, they ...
Attention deficit hyperactivity disorder (ADHD) is a condition that can affect all stages of life. Medication is not the only treatment, but it is often the treatment that can make the most obvious ...
New ADHD medications come with higher price tags but not always better results. Here’s what actually matters when choosing the right treatment.
Amid rising diagnoses, a growing number of kids are getting prescriptions for ADHD medications — but the administered doses aren’t always accurate. Medication ...
"No one should reach later adulthood without answers simply because the condition was less understood when they were younger.
Attention-deficit/hyperactivity disorder, or ADHD, is one of the most common neurodevelopmental conditions in the United ...
You go out for happy hour with your work friend and indulge in a nice espresso martini. Your phone alarm dings, and you realize it’s time to take your daily ...
But some commonly prescribed drugs interfere with these processes, making it harder to stay cool. Here are a few you should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results